David R. Bauer
Lawyers
Filters
Illumina $500 million notes offering
The 4.65% investment-grade notes are due 2026
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
Eli Lilly $5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Generation Bio $237 million at-the-market offering
The shares are listed on Nasdaq
MicroStrategy $2 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
InflaRx $75 million at-the-market offering
The shares are listed on the Nasdaq Global Market